Tang Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.4M | Buy |
2,328,609
+210,030
| +10% | +$5.81M | 3.26% | 5 |
|
|
2025
Q1 | $47.1M | Buy |
2,118,579
+1,489,970
| +237% | +$33.1M | 2.6% | 10 |
|
|
2024
Q4 | $12.4M | Hold |
628,609
| – | – | 0.82% | 35 |
|
|
2024
Q3 | $15.7M | Buy |
628,609
+3,300
| +0.5% | +$82.5K | 1.12% | 26 |
|
|
2024
Q2 | $11.7M | Buy |
625,309
+125,309
| +25% | +$2.34M | 1.19% | 29 |
|
|
2024
Q1 | $9.87M | Sell |
500,000
-100,000
| -17% | -$1.97M | 1.03% | 33 |
|
|
2023
Q4 | $10.5M | Hold |
600,000
| – | – | 0.97% | 28 |
|
|
2023
Q3 | $10.4M | Hold |
600,000
| – | – | 1.47% | 21 |
|
|
2023
Q2 | $8.45M | Hold |
600,000
| – | – | 1.24% | 30 |
|
|
2023
Q1 | $6.46M | Hold |
600,000
| – | – | 0.96% | 34 |
|
|
2022
Q4 | $8.99M | Hold |
600,000
| – | – | 1.31% | 22 |
|
|
2022
Q3 | $7.7M | Hold |
600,000
| – | – | 0.94% | 33 |
|
|
2022
Q2 | $5.81M | Buy |
600,000
+100,000
| +20% | +$969K | 0.88% | 28 |
|
|
2022
Q1 | $4.97M | Buy |
+500,000
| New | +$4.97M | 0.99% | 30 |
|